ABCB1 genetic variants in leukemias: current insights into treatment outcomes

References

• National Cancer InstituteLeukemiaBethesda, MDNational Cancer Institute2013 Available from: http://www.cancer.gov/cancertopics/types/leukemia
   Google Scholar
• National Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia Version 42013 Available from: http://www.nccn.org/professionals/physician_gls/pdf/cml.pdf
   Google Scholar
• HamadaASahliZEl SabbanMMouteirikMNasrREmerging therappeutic strategies for targeting chronic myeloid leukemia stel cellStem Cell Int2013724360
   Web of Science ®Google Scholar
• BaccaraniMDeiningerMWRostiGEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemiaBlood2013122687288423803709
   PubMed Web of Science ®Google Scholar
• HochhausAO’brienSGuilhotFSix-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaLeukemia20092361054106119282833
   PubMed Web of Science ®Google Scholar
• NasrRBazarbachiAChronic myeloid leukemia:” archetype” of the impact of targeted therapiesPathologie-biologie201260423924522743097
   PubMedGoogle Scholar
• BixbyDTalpazMMechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistanceHematology Am Soc Hematol2009461476
   Google Scholar
• PuiCHChengCLeungWExtended follow-up of long-term survivors of childhood acute lymphoblastic leukemiaN Engl J Med2003349764064912917300
   PubMed Web of Science ®Google Scholar
• CheokMHLugthartSEvansWEPharmacogenomics of acute leukemiaAnnu Rev Pharmacol Toxicol20064631735316402908
   PubMed Web of Science ®Google Scholar
• EvansWEMcLeodHLPharmacogenomics – drug disposition, drug targets, and side effectsN Engl J Med2003348653854912571262
   PubMed Web of Science ®Google Scholar
• EvansWERellingMVMoving towards individualized medicine with pharmacogenomicsNature2004429699046446815164072
   PubMed Web of Science ®Google Scholar
• EvansWERellingMVPharmacogenomics: translating functional genomics into rational therapeuticsScience1999286543948749110521338
   PubMed Web of Science ®Google Scholar
• RellingMVDervieuxTPharmacogenetics and cancer therapyNat Rev Cancer2001129910811905809
   PubMed Web of Science ®Google Scholar
• BorstPElferinkROMammalian ABC transporters in health and diseaseAnnu Rev Biochem200271153759212045106
   PubMed Web of Science ®Google Scholar
• GottesmanMMMechanisms of cancer drug resistanceAnnu Rev Med200253161562711818492
   PubMed Web of Science ®Google Scholar
• AmbudkarSVKimchi-SarfatyCSaunaZEGottesmanMMP-glycoprotein: from genomics to mechanismOncogene200322477468748514576852
   PubMed Web of Science ®Google Scholar
• ClayATSharomFJMultidrug resistance proteinYouGMorrisMEDrug Transporters: Molecular Characterization and Role in Drug Disposition2nd edHoboken, NJJohn Wiley & Sons2014141160
   Google Scholar
• FrommMFImportance of P-glycoprotein at blood–tissue barriersTrends Pharmacol Sci200425842342915276711
   PubMed Web of Science ®Google Scholar
• WolkingSSchaeffelerELercheHSchwabMNiesATImpact of genetic polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on drug disposition and potential clinical implications: update of the literatureClin Pharmacokinet201554770973525860377
   PubMed Web of Science ®Google Scholar
• BodorMKelleyEJHoRJCharacterization of the humanMDR1 geneAAPS J200571E1E516146331
   PubMed Web of Science ®Google Scholar
• SharomFJThe P-glycoprotein multidrug transporterEssays Biochem201150116117821967057
   PubMed Web of Science ®Google Scholar
• EfferthTThe human ATP-binding cassette transporter genes from the bench to the bedsideCurr Mol Med200111456511899242
   PubMedGoogle Scholar
• O’ConnorRThe pharmacology of cancer resistanceAnticancer Res2007273A1267127217593618
   PubMed Web of Science ®Google Scholar
• Leveille-WebsterCRAriasIMThe biology of the P-glycoproteinsJ Membr Biol19951432891027731035
   PubMed Web of Science ®Google Scholar
• LeschzinerGDAndrewTPirmohamedMJohnsonMRABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future researchPharmacogenomics J20077315417916969364
   PubMed Web of Science ®Google Scholar
• Pauli-MagnusCKroetzDLFunctional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1)Pharm Res200421690491315212152
   PubMed Web of Science ®Google Scholar
• WolfSBachtiarMWangJSimTChongSLeeCAn update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokineticsPharmacogenomics J201111531532521625253
   PubMed Web of Science ®Google Scholar
• IeiriITakaneHOtsuboKThe MDR1 (ABCB1) gene polymorphism and its clinical implicationsClin Pharmacokinet200443955357615217301
   PubMed Web of Science ®Google Scholar
• MarzoliniCPausEBuclinTKimRBPolymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceClin Pharmacol Ther2004751133314749689
   PubMed Web of Science ®Google Scholar
• HodgesLMMarkovaSMChinnLWVery important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Pharmacogenet Genomics201121315220216335
   PubMed Web of Science ®Google Scholar
• CascorbiIRole of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugsPharmacol Ther2006112245747316766035
   PubMed Web of Science ®Google Scholar
• Kimchi-SarfatyCMarpleAHShinarSEthnicity-related polymorphisms and haplotypes in the human ABCB1 genePharmacogenomics200781293917187507
   PubMed Web of Science ®Google Scholar
• LongoRD’AndreaMSarmientoRGaspariniGPharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumabExpert Opin Investig Drugs201019Suppl 1S41S50
   PubMed Web of Science ®Google Scholar
• SissungTMGardnerERPiekarzRLImpact of ABCB1 allelic variants on QTc interval prolongationClin Cancer Res201117493794621106724
   PubMed Web of Science ®Google Scholar
• HoffmeyerSBurkOVon RichterOFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProc Natl Acad Sci20009773473347810716719
   PubMed Web of Science ®Google Scholar
• HitzlMDrescherSvan der KuipHThe C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cellsPharmacogenetics200111429329811434506
   PubMedGoogle Scholar
• WangDJohnsonADPappACKroetzDLSadeeWMultidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C> T affects mRNA stabilityPharmacogenetics20051510693704
   Google Scholar
• IshikawaTHiranoHOnishiYSakuraiATaruiSFunctional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analysesDrug Metab Pharmacokinet200419111415499164
   PubMedGoogle Scholar
• SakuraiAOnishiYHiranoHQuantitative Structure – activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-Glycoprotein/MDR1)Biochemistry200746267678769317559192
   PubMed Web of Science ®Google Scholar
• KomotoCNakamuraTSakaedaTMDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancerDrug Metab Pharmacokinet200621212613216702732
   PubMed Web of Science ®Google Scholar
• DandaraCLombardZDu PlooyIMcLellanTNorrisSARamsayMGenetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and-3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversityPharmacogenomics201112121663167022118051
   PubMed Web of Science ®Google Scholar
• WuHKangHLiuYRoles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomesJ Cancer Res Clin Oncol201213891449146222526155
   PubMed Web of Science ®Google Scholar
• KimRBLeakeBFChooEFIdentification of functionally variant MDR1 alleles among European Americans and African AmericansClin Pharmacol Ther200170218919911503014
   PubMed Web of Science ®Google Scholar
• KroetzDLPauli-MagnusCHodgesLMSequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) genePharmacogenetics200313848149412893986
   PubMedGoogle Scholar
• FerraraFTreatment of unfit patients with acute myeloid leukemia: a still open clinical challengeClin Lymphoma Myeloma Leuk2011111101621454185
   PubMed Web of Science ®Google Scholar
• SmithMLHillsRKGrimwadeDIndependent prognostic variables in acute myeloid leukaemiaBlood Rev2011251395121078537
   PubMed Web of Science ®Google Scholar
• WuchterCLeonidKRuppertVClinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemiaHaematologica200085771172110897123
   PubMed Web of Science ®Google Scholar
• NakamuraTSakaedaTHorinouchiMEffect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjectsClin Pharmacol Ther200271429730311956513
   PubMed Web of Science ®Google Scholar
• LeithCPKopeckyKJChenIMFrequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group StudyBlood19999431086109910419902
   PubMed Web of Science ®Google Scholar
• SeedhouseCHGrundyMWhitePSequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trialsClin Cancer Res200713237059706618056183
   PubMed Web of Science ®Google Scholar
• ScheinerMAda Cunha VasconcelosFda MattaRRDal Bello FigueiraRJrMaiaRCABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patientsJ Cancer Res Clin Oncol2012138695996922358301
   PubMed Web of Science ®Google Scholar
• GreenHFalkIJLotfiKAssociation of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotypePharmacogenomics J201212211111820938465
   PubMed Web of Science ®Google Scholar
• FalkJIFyrbergAPaulEImpact of ABCB1 single nucleotide polymorphisms 1236C> T and 2677G> T on overall survival in FLT3 wild type de novo AML patients with normal karyotypeBr J Haematol2014167567168025155901
   PubMed Web of Science ®Google Scholar
• HeHYinJLiXAssociation of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemiaEur J Clin Pharmacol201571329330225567217
   PubMed Web of Science ®Google Scholar
• Megías-VericatJRojasLHerreroMInfluence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studiesPharmacogenomics J201515210911825558979
   PubMed Web of Science ®Google Scholar
• GattaGBottaLRossiSChildhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based studyLancet Oncol2014151354724314616
   PubMed Web of Science ®Google Scholar
• PuiCHEvansWETreatment of acute lymphoblastic leukemiaN Engl J Med2006354216617816407512
   PubMed Web of Science ®Google Scholar
• DawidowskaMKosmalskaMSędekŁAssociation of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALLSci Rep201662942727427275
   PubMed Web of Science ®Google Scholar
• López-LópezEGutiérrez-CaminoÁPiñánMÁPharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemiaPloS One201493e9126124614921
   PubMed Web of Science ®Google Scholar
• DavidsenMLDalhoffKSchmiegelowKPharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemiaJ Pediatric Hematol Oncol20083011831849
   Web of Science ®Google Scholar
• MoriyamaTRellingMVYangJJInherited genetic variation in childhood acute lymphoblastic leukemiaBlood2015125263988399525999454
   PubMed Web of Science ®Google Scholar
• JamroziakKMłynarskiWBalcerczakEFunctional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemiaEur J Haematol200472531432115059065
   PubMed Web of Science ®Google Scholar
• StanullaMSchäffelerEArensSGSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemiaInt J Hematol2005811394415717687
   PubMed Web of Science ®Google Scholar
• EfferthTSauerbreyASteinbachDAnalysis of single nucleotide polymorphism C3435T of the multi-drug resistance gene MDR1 in acute lymphoblastic leukemiaInt Journal Oncol2003232509518
   PubMed Web of Science ®Google Scholar
• JamroziakKBalcerczakECebulaBMulti-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemiaPharmacol Rep200557688288816382213
   PubMed Web of Science ®Google Scholar
• CeppiFLanglois-PelletierCGagnéVPolymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaPharmacogenomics20141581105111625084203
   PubMed Web of Science ®Google Scholar
• ErdélyiDJKamoryEZalkaAThe role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, retrospective study in childhood acute lymphoblastic lleukemiaCellular Immunol2016244121124
   Web of Science ®Google Scholar
• GregersJChristensenIJDalhoffKThe association of reduced folate carrier 80G> A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy numberBlood2010115234671467720335220
   PubMed Web of Science ®Google Scholar
• BorstLWallerekSDalhoffKThe impact of CYP3A5* 3 on risk and prognosis in childhood acute lymphoblastic leukemiaEur J Haematol201186647748321418106
   PubMed Web of Science ®Google Scholar
• BorstLBuchardARosthøjSGene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemiaJ Pediatr Hematol Oncol2012341384222215096
   PubMed Web of Science ®Google Scholar
• GrabarPBRojkoSLogarDDolžanVGenetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathwayAnn Rheum Dis201069593193220413572
   PubMed Web of Science ®Google Scholar
• KatoTHamadaAMoriSSaitoHGenetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritisDrug Metab Pharmacokinet201227219219922104130
   PubMed Web of Science ®Google Scholar
• GregersJGreenHChristensenIJPolymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemiaPharmacogenomics J201515437237925582575
   PubMed Web of Science ®Google Scholar
• LiuSGaoCZhangRGermline genetic variations in methotrexate candidate genes are associated with pharmacokinetics and outcome in paediatric acute lymphoblastic leukemia in ChinaBlood20161281595
   Web of Science ®Google Scholar
• YangJJChengCDevidasMGenome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaBlood2012120204197420423007406
   PubMed Web of Science ®Google Scholar
• ZgheibNKAkra-IsmailMAridiCGenetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemiaPharmacogenet Genomics201424838739625007187
   PubMed Web of Science ®Google Scholar
• KishiSChengCFrenchDAncestry and pharmacogenetics of antileukemic drug toxicityBlood2007109104151415717264302
   PubMed Web of Science ®Google Scholar
• GuilhaumouRSolasCBourgarel-ReyVImpact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicityCancer Chemother Pharmacol20116861633163821968951
   PubMed Web of Science ®Google Scholar
• JabbourEParikhSAKantarjianHCortesJChronic myeloid leukemia: mechanisms of resistance and treatmentHematol Oncol Clin North Am201125598199522054730
   PubMed Web of Science ®Google Scholar
• GardnerERBurgerHSchaikRHAssociation of enzyme and transporter genotypes with the pharmacokinetics of imatinibClin Pharmacol Ther200680219220116890580
   PubMed Web of Science ®Google Scholar
• GurneyHWongMBalleineRImatinib disposition and ABCB1 (MDR1, P Glycoprotein) genotypeClin Pharmacol Ther2007821334017495881
   PubMed Web of Science ®Google Scholar
• MahonFXBellocFLagardeVMDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line modelsBlood200310162368237312609962
   PubMed Web of Science ®Google Scholar
• BurgerHvan TolHBoersmaAWImatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpBlood200410492940294215251980
   PubMed Web of Science ®Google Scholar
• SailajaKSurekhaDNageswara RaoDRaghunadha RaoDVishnupriyaSABCB1 (MDR1, P-glycoprotein) C3435T gene polymorphism and its possible association with chronic myeloid leukemia prognosisCurr Trends Biotechnol Pharm20082514522
   Google Scholar
• DulucqSPreudhommeCGuilhotFMahonFXResponse: is there really a relationship between Multidrug Resistance Gene (MDR1) polymorphisms and major molecular response to imatinib in chronic myeloid leukemia?Blood20101162661456146
   Web of Science ®Google Scholar
• AngeliniSSoveriniSRavegniniGAssociation between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapyHaematologica201398219320022875622
   PubMed Web of Science ®Google Scholar
• NiLNLiJYMiaoKRMultidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemiaMedical Oncol2011281265269
   PubMed Web of Science ®Google Scholar
• MaffioliMCamósMGayaACorrelation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemiaLeuk Res20113581014101921185600
   PubMed Web of Science ®Google Scholar
• AuABabaAAGohASAssociation of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patientsBiomed Pharmacother201468334334924581936
   PubMed Web of Science ®Google Scholar
• SalimizandHAminiSAbdiMGhaderiBAzadiNAConcurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemiaTumor Biology201637179179826250462
   PubMedGoogle Scholar
• DulucqSBouchetSTurcqBMultidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemiaBlood200811252024202718524988
   PubMed Web of Science ®Google Scholar
• GalimbertiSCervettiGGuerriniFQuantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatmentCancer Genet Cytogenet20051621576216157201
   PubMedGoogle Scholar
• ElghannamDMIbrahimLEbrahimMAAzmyEHakemHAssociation of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patientsHematology201419312312823683876
   PubMed Web of Science ®Google Scholar
• DeenikWvan der HoltBJanssenJJPolymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinibBlood2010116266144614521183698
   PubMed Web of Science ®Google Scholar
• ZuBLiYWangXHeDHuangZFengWMDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysisPharmacogenomics201415566767724798723
   PubMed Web of Science ®Google Scholar
• ZhengQWuHYuQABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysisPharmacogenomics J201515212713425245580
   PubMed Web of Science ®Google Scholar
• SinghOChanJYLinKHengCCChowbayBSLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in asian patients with chronic myeloid leukemiaPloS One2012712e5177123272163
   PubMed Web of Science ®Google Scholar
• SkoglundKMorenoSBJönssonJIGréenHFunctional characterization of ABCG2 polymorphisms and their influence on tyrosine kinase inhibitor effects in chronic myeloid leukemia cellsBlood20111182134953495
   Web of Science ®Google Scholar
• AliMAElsalakawyWAABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylateMed Oncol20143111110
   Web of Science ®Google Scholar
• EadieLNDangPSaundersVAThe clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatmentLeukemia20173111827389053
   PubMed Web of Science ®Google Scholar
• EspositoNNew Bcr-Abl-independent mechanisms of resistance to imatinib treatment in chronic myelogenous leukaemia patients, Università degli Studi di Napoli Federico II2008
   Google Scholar
• DessillyGPaninNElensLHaufroidVDemoulinJBImpact of ABCB1 1236C> T-2677G> T-3435C> T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinibSci Rep201662955927405085
   PubMed Web of Science ®Google Scholar
• JamroziakKBalcerczakESmolewskiPMDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemiaPharmacol Rep200658572017085864
   PubMed Web of Science ®Google Scholar
• DongHJMiaoKRQiaoCPolymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese populationLeuk Lymphoma20115261003100921463115
   PubMed Web of Science ®Google Scholar
• PennaGAllegraAAlonciAMDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an imppact on susceptibility and prognosisMed Oncol2011281549155420496015
   PubMed Web of Science ®Google Scholar
• MarchettiSMazzantiRBeijnenJHSchellensJHConcise review: clinical relevance of drug–drug and herb–drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)Oncologist200712892794117766652
   PubMed Web of Science ®Google Scholar
• ArberDAOraziAHasserjianRThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood2016127202391240527069254
   PubMed Web of Science ®Google Scholar
• MeyerUAZangerUMSchwabMOmics and drug responseAnn Rev Pharmacol201353475502
   Google Scholar
• ZakimDSchwabMData collection as a barrier to personalized medicineTrends Pharmacol Sci201536687125479798
   PubMed Web of Science ®Google Scholar